| 2006 |
| |
Pursuing its unremitting quest to reach the highest
Quality standards, EBC is awarded the overall
ISO 9001 Certification embracing its entire sphere of expertise:
National and international epidemiological surveys, Promotional campaigns, Professional Relationships
|
| 2003 |
| |
FOVEA continues its relentless efforts to reach the highest standards of Quality: On 26th February 2003, it is successfully awarded the 2000 edition upgrade of the ISO 9001 International Standards
|
| |
| |
FOVEA and EBC carry on developing their skills and competence: From their base in Rueil-Malmaison, they successfully manage several major surveys in over 35 countries - in Europe, but also in Africa, North America, Asia and the Middle East
|
| 2002 |
| |
FOVEA and EBC increase their paid-up capitals to respectively 150,000 euros and 16,000 euros
|
| |
| |
Continued development of the synergies between EVIDENCE Based Communication and FOVEA: Invited to tender for 20 projects, the FOVEA group is retained to execute 15 of them
|
| |
| |
FOVEA reacts to an ever-increasing demand for organising set-up reunions and results presentations (FOVEA Clinical Research/EBC), as well as communication strategies (FOVEA Marketing Studies/EBC)
|
| 2001 |
| |
Creation of EVIDENCE Based Communication, headed by Armand SEDEFDJIAN
FOVEA increases its paid-up capital to 100,000 euros
|
| 2000 |
| |
In an ever-increasing competitive and internationalised environment, FOVEA:
|
| |
|  |
becomes one of the very first CROs to be awarded the ISO 9001 Certification
|
| |
|  |
initiates on-line studies with several Sponsors
|
| 1999 |
| |
FOVEA implements a policy of partnership with a leading international network in order to conduct clinical trials at the European level
|
| 1998 |
| |
FOVEA becomes a Limited Company with a paid-up capital of 250,000 FF
|
| 1993 |
| |
FOVEA adds Conception of Studies and Monitoring activities to the Department of Clinical Studies to offer its customers enhanced services and skills in clinical trials
|
| 1990 |
| |
In order to offer a broader expertise to the Pharmaceutical Industry, FOVEA introduces 2 new activities:
|
| |
|  |
Biometry services within the Department of Clinical Studies run by Franck Sévenier
|
| |
|  |
Market and Products Studies (qualitative and quantitative) within the Department of Marketing Studies run by Eric Ohayon
|
| 1988 |
| |
After having instituted a third-year Pharmaceutical Marketing curriculum at the Institut Supérieur de Gestion (Ecole de Commerce de Paris), Eric Ohayon (a biochemist by training) and Franck Sévenier (a Doctor of Medicine as well as a statistician) create FOVEA, a company specifically tailored to conduct quantitative Markets and Products Studies on behalf of the Pharmaceutical Industry |